| Financial Year |
March 31 2023 |
| Monetary Funds |
761,674,263.70 |
| Held-for-trading Financial Assets |
169,179,350.67 |
| Notes Receivable |
24,962,920.65 |
| Accounts Receivable |
2,435,308,961.39 |
| Advances to Suppliers |
59,916,214.08 |
| Other Receivables |
331,988,238.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,070,205.48 |
| Dividend Receivable |
-- |
| Inventories |
284,828,949.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,852,243.88 |
| Total Current Assets |
5,241,972,770.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
469,840,475.44 |
| Long-term Equity Investment |
463,805,299.65 |
| Investment Properties |
14,458,640.69 |
| Fixed Assetes |
404,773,870.47 |
| Under-construction Projects |
6,596,634.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,842,053.36 |
| R&D expenses |
-- |
| Goodwill |
78,767,226.52 |
| Long-Term Deferred and Prepaid Expenses |
5,875,430.67 |
| Deferred Income Tax Assets |
187,368,067.06 |
| Other Non-Current Assets |
400,000.00 |
| Sub-Total of Non-Current Assets |
1,833,370,137.94 |
| Total Assets |
7,075,342,908.28 |
| Short-Term Loans |
1,362,403,068.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
185,934,599.77 |
| Accounts Payable |
1,005,184,335.24 |
| Accounts Received In Advance |
1,248,504.02 |
| Employee Compensation Payable |
83,925,504.69 |
| Taxes Payable |
123,560,033.51 |
| Interest Payable |
-- |
| Dividend Payable |
1,219,911.89 |
| Other payables |
152,501,075.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
216,302,360.93 |
| Other Current Liabilities |
10,322,029.77 |
| Sub-Total of Current Liabilities |
3,296,848,144.00 |
| Long-term Loans |
49,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
231,294,301.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,875,578.55 |
| Other Non-Current Liabilities |
22,239,573.17 |
| Sub-Total of Non-Current Liabilities |
322,823,591.55 |
| Total Liabilities |
3,619,671,735.55 |
| Paid-In Capital(Or Share Stock) |
313,804,147.00 |
| Capital Surplus |
743,077,823.50 |
| Surplus Reserve |
221,418,969.78 |
| LESS:Treasury Stock |
17,812,327.20 |
| Undistributed Profits |
2,073,771,455.17 |
| Minority Stockholder's Interest |
68,356,022.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,387,315,150.60 |
| Owner's Equity（Stockholder's Equity） |
3,455,671,172.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,075,342,908.28 |
